$EXPO
EXPONENT INC

2018 Q2 Form 10-Q Financial Statement

#000114420418041932 Filed on August 03, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $95.62M $87.84M
YoY Change 8.86% 5.63%
Cost Of Revenue $5.600M $3.700M
YoY Change 51.35% -11.9%
Gross Profit $90.00M $84.10M
YoY Change 7.02% 6.46%
Gross Profit Margin 94.12% 95.74%
Selling, General & Admin $59.90M $56.50M
YoY Change 6.02% 1.8%
% of Gross Profit 66.56% 67.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.500M $1.600M
YoY Change -6.25% 14.29%
% of Gross Profit 1.67% 1.9%
Operating Expenses $73.14M $63.80M
YoY Change 14.64% -4.38%
Operating Profit $22.48M $20.32M
YoY Change 10.64% 23.61%
Interest Expense $500.0K $300.0K
YoY Change 66.67% 200.0%
% of Operating Profit 2.22% 1.48%
Other Income/Expense, Net $2.441M $2.031M
YoY Change 20.19% 56.47%
Pretax Income $24.92M $22.35M
YoY Change 11.5% 26.02%
Income Tax $6.494M $8.557M
% Of Pretax Income 26.06% 38.29%
Net Earnings $18.43M $13.79M
YoY Change 33.6% -10.16%
Net Earnings / Revenue 19.27% 15.7%
Basic Earnings Per Share $0.35 $0.26
Diluted Earnings Per Share $0.34 $0.26
COMMON SHARES
Basic Shares Outstanding 53.01M 52.83M
Diluted Shares Outstanding 54.20M 53.94M

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $193.3M $162.0M
YoY Change 19.32% 4.52%
Cash & Equivalents $117.8M $90.23M
Short-Term Investments $75.50M $71.80M
Other Short-Term Assets $9.200M $9.300M
YoY Change -1.08% -20.51%
Inventory
Prepaid Expenses
Receivables $116.5M $107.4M
Other Receivables $0.00 $0.00
Total Short-Term Assets $319.0M $278.7M
YoY Change 14.46% 6.5%
LONG-TERM ASSETS
Property, Plant & Equipment $41.40M $35.90M
YoY Change 15.32% 25.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.70M $86.50M
YoY Change 0.23% 9.91%
Total Long-Term Assets $136.7M $131.0M
YoY Change 4.35% 13.22%
TOTAL ASSETS
Total Short-Term Assets $319.0M $278.7M
Total Long-Term Assets $136.7M $131.0M
Total Assets $455.7M $409.7M
YoY Change 11.23% 8.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.40M $10.60M
YoY Change 16.98% 29.27%
Accrued Expenses $56.80M $50.90M
YoY Change 11.59% 27.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.30M $68.10M
YoY Change 13.51% 24.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $59.70M $52.20M
YoY Change 14.37% 4.19%
Total Long-Term Liabilities $59.70M $52.20M
YoY Change 14.37% 4.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.30M $68.10M
Total Long-Term Liabilities $59.70M $52.20M
Total Liabilities $136.9M $120.3M
YoY Change 13.8% 14.68%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 13.67M shares 7.060M shares
Shareholders Equity $318.8M $289.4M
YoY Change
Total Liabilities & Shareholders Equity $455.7M $409.7M
YoY Change 11.23% 8.56%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income $18.43M $13.79M
YoY Change 33.6% -10.16%
Depreciation, Depletion And Amortization $1.500M $1.600M
YoY Change -6.25% 14.29%
Cash From Operating Activities $24.20M $19.00M
YoY Change 27.37% 6233.33%
INVESTING ACTIVITIES
Capital Expenditures $2.139M $1.219M
YoY Change 75.47% -17.69%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$4.000M
YoY Change -100.0% -62.26%
Cash From Investing Activities -$2.200M -$5.200M
YoY Change -57.69% -56.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.400M -11.00M
YoY Change -41.82% -28.57%
NET CHANGE
Cash From Operating Activities 24.20M 19.00M
Cash From Investing Activities -2.200M -5.200M
Cash From Financing Activities -6.400M -11.00M
Net Change In Cash 15.60M 2.800M
YoY Change 457.14% -110.33%
FREE CASH FLOW
Cash From Operating Activities $24.20M $19.00M
Capital Expenditures $2.139M $1.219M
Free Cash Flow $22.06M $17.78M
YoY Change 24.07% -1605.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6494000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8557000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
44076000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1073000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
500000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2220000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4307000 USD
us-gaap Net Income Loss
NetIncomeLoss
38765000 USD
us-gaap Net Income Loss
NetIncomeLoss
30367000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52876000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52716000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54111000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53960000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.26
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47369000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39758000 USD
us-gaap Operating Expenses
OperatingExpenses
148002000 USD
us-gaap Operating Expenses
OperatingExpenses
137011000 USD
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
454000 USD
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17076000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-629000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
590000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3149000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3195000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-153000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-205000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
782000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
805000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10033000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1217000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20840000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4553000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3365000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3018000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
928000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8182000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9806000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-295000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1022000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27916000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17191000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8949000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2526000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
16000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12888000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15526000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9520000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7004000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
638000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
10995000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21677000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26881000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24734000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90233000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
13000000 USD
CY2018Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
140288000 USD
CY2018Q2 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
62196000 USD
CY2018Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
62196000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6267000 USD
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
134696000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9742000 USD
CY2017Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
59050000 USD
CY2018Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
193728000 USD
CY2018Q2 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
421000 USD
CY2018Q2 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
193307000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
196791000 USD
CY2017Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2017Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
393000 USD
CY2017Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
196398000 USD
CY2018Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
43947000 USD
CY2018Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
32008000 USD
CY2018Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
75955000 USD
CY2018Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
43784000 USD
CY2018Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
31750000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
235164 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7004000 USD
CY2018Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
45376000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5892000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5667000 USD
CY2018Q2 us-gaap Trading Securities
TradingSecurities
58487000 USD
CY2017Q4 us-gaap Trading Securities
TradingSecurities
53350000 USD
CY2018Q2 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
62196000 USD
CY2017Q4 expo Deferred Compensation Plan Vested Amounts Due
DeferredCompensationPlanVestedAmountsDue
59050000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
12217000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8522000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7643000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6910000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
691000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
135000 USD
CY2018Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2139000 USD
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1219000 USD
CY2018Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1594000 USD
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1629000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2029000 USD
CY2018Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3644000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3526000 USD
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000 shares
CY2018Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13669000 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
14169000 shares
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2441000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2031000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3293000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4807000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
19000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
1043000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
737000 USD
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
2917000 USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.105
CY2017Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.105
CY2017Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.105
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.420
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5374000 USD
CY2017Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5424000 USD
CY2017Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5424000 USD
CY2017Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5416000 USD
CY2017 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21638000 USD
CY2018Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2018Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.26
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2018Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2671000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4604000 USD
CY2018Q2 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
5800000 USD
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
11400000 USD
CY2018Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure

Files In Submission

Name View Source Status
0001144204-18-041932-index-headers.html Edgar Link pending
0001144204-18-041932-index.html Edgar Link pending
0001144204-18-041932.txt Edgar Link pending
0001144204-18-041932-xbrl.zip Edgar Link pending
expo-20180629.xml Edgar Link completed
expo-20180629.xsd Edgar Link pending
expo-20180629_cal.xml Edgar Link unprocessable
expo-20180629_def.xml Edgar Link unprocessable
expo-20180629_lab.xml Edgar Link unprocessable
expo-20180629_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv498965_10q.htm Edgar Link pending
tv498965_ex3-1.htm Edgar Link pending
tv498965_ex31-1.htm Edgar Link pending
tv498965_ex31-2.htm Edgar Link pending
tv498965_ex32-1.htm Edgar Link pending
tv498965_ex32-2.htm Edgar Link pending